[QUOTE=TooColdNJ;1810257]
With the onset of COVID-19, I’m sure that the same thing is happening with HCQ— Yale professors and doctors have no scientific proof and are probably cashing in on claims that it could have an effect on the virus— probably for their own personal gains.[QUOTE]
Possibly the most error filled comment in a thread that's full of them
HCQ costs about $5 for a weeks supply. There is no patent on this drug and it is made worldwide by several companies. There are ZERO Doctors, epidemiologists, or scientists who are getting paid to endorse this drug. If they recommend it, it's simply because they are getting good results.
Want to explore Big Pharma drug corruption? Eight members of the National Institutes of Health (NIH) expert COVID-19 Treatment Guideline Panel are on Gilead's payroll. Gilead makes Remdesivir, the drug that cost hospitals $3000-$5000 per patient and has no statistical effect on covid 19 deaths. The NIH panel allowed the Remdesivir trial to change their endpoints during the trial from measuring effects on mortality to effects on hospital stay.
If readers want to explore 65 studies on HCQ, both good and bad, see post #54 and forget all the political chatter.
|